G Laufer

Outcomes of Donor-Recipient Gender Mismatched Lung Transplantation in the Eurotransplant Area

J.M. Kwakkel- van Erp, Jacqueline M. Smits, Veronique Verplancke, Patrick Evrard et autres

be, nl, at, de (code pays fourni par la source)

Long term effect of the heart donor score on patient survival

J.M.M. Smits, Michel De Pauw, Udo Emmanuel Samuel, Bruno Meiser et autres

Aspirin and clopidogrel non-responder in patients with a left ventricular assist device

Julia Riebandt, Stéphane Mahr, T. Haberl, Simon Panzer et autres

Objectives: Thromboembolic complications are a deleterious adverse event after left ventricular assist device (LVAD) implantation. Because of individual responsiveness to antiplatelet treatment with the COX-inhibitor aspirin and P2Y12-inhibitor clopidogrel, personalized treatment based on platelet function testing may significantly reduce thromboembolic complications in …

at (code pays fourni par la source)

2000 patient years of follow up after the Ross Procedure in a single center

Martin Andreas, Gernot Seebacher, E Reida, Dominik Wiedemann et autres

Objective: The Ross Procedure offers several advantages in a young patient population requiring aortic valve replacement. Outcome data after the Ross Procedure are still conflicting. Reoperations are usually due to pulmonary homograft stenosis or autograft dilatation and are a matter of concern. …

at (code pays fourni par la source)

PROTON PUMP INHIBITORS IMPACT CYCLOSPORINE DOSE/EXPOSURE RELATION IN DE NOVO HTXR TREATED WITH MMF OR EVEROLIMUS - EMPHASIS OF THERAPEUTIC DRUG MONITORING

C. Bara, G Laufer, M. Crespo, T.J. Dengler et autres

Bara, C.1; Laufer, G.2; Crespo, M. G.3; Dengler, T. J.4; Karpov, A.5; Potena, L.6; Schwende, H.7; Varnous, S.8; Junge, G.9 Author Information

de, at, es, ch, it, fr (code pays fourni par la source)

113: Impact of 1 Year Creatinine on Long-Term Survival after Cardiac Transplantation

A.Z. Aliabadi, Stéphane Mahr, Daniela Dunkler, M. Groemmer et autres

at (code pays fourni par la source)

Contents, Vol. 25, Supplement 2, 1985

O. Dapunt, H. Pickel, M. Lahousen, W. Lichtenegger et autres

Autorenregister

O. Dapunt, H. Pickel, M. Lahousen, W. Lichtenegger et autres

Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery

Nikolaos Bonaros, Diana Hennerbichler, Fatiha Guy, Agnes Kocher et autres

Introduction: The relationship between previous elective PCI and the perioperative outcome after CABG remains undetermined. The aim of the study was to investigate whether patients referred to CABG after previous elective PCI have an increased perioperative risk. Methods: Between January 2002 and …

at (code pays fourni par la source)

Is the myocardial enzyme release in totally endoscopic CABG on the arrested heart tolerable?

Thomas Schachner, Nikolaos Bonaros, Elisabeth Ruetzler, F Weidinger et autres

Aims: Robotic totally endoscopic CABG (TECAB) enables coronary artery bypass grafting without sternotomy or thoracotomy. However longer CPB times and aortic endoocclusion times are currently required as compared with standard CABG operations. We investigated if longer operation times affect the myocardial enzyme …

at (code pays fourni par la source)

396: Everolimus in de novo heart transplant recipients: Six month data on cyclosporine reduction and impact on renal function

Anne Keogh, Shoei‐Shen Wang, Andreas Zuckermann, Heather J. Ross et autres

au, tw, at, ca, it, us, de, ch (code pays fourni par la source)

Increased cell engraftment and neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors in ischemic heart failure

Nikolaos Bonaros, Rauend Rauf, B Schlechta, Alfred Kocher et autres

Objectives: Combined transplantation of skeletal myoblasts (SM) and AC-133+cells (SC) leads to improved left ventricular function, and reduced infarct size in ischemic heart failure. The aim of this study is to elucidate on the possible mechanisms of increasing cell therapy efficacy. Methods: …

at (code pays fourni par la source)